The in house manufacturing plant helps to extend Sohm’s core competence to include neutraceutical at a right time when the United States Food & Drug Administration and the Indian Food & Drug Administration are simplifying regulations in regard to neutraceutical deliverables.
Sohm president and CEO Shailesh Shah said the new plant is in compliance with all Dietary Supplement Health and Education Guidelines.
The company has also received an endorsement and necessary regulatory compliances with local authority as well as with the Indian Food & Drug Administration and Food Standards Authority of India.